Annual Total Liabilities
$92.36 M
+$701.00 K+0.76%
December 31, 2023
Summary
- As of February 6, 2025, ITOS annual total liabilities is $92.36 million, with the most recent change of +$701.00 thousand (+0.76%) on December 31, 2023.
- During the last 3 years, ITOS annual total liabilities has risen by +$71.00 million (+332.38%).
- ITOS annual total liabilities is now -72.17% below its all-time high of $331.89 million, reached on December 31, 2021.
Performance
ITOS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$91.39 M
+$3.41 M+3.88%
September 30, 2024
Summary
- As of February 6, 2025, ITOS quarterly total liabilities is $91.39 million, with the most recent change of +$3.41 million (+3.88%) on September 30, 2024.
- Over the past year, ITOS quarterly total liabilities has dropped by -$975.00 thousand (-1.06%).
- ITOS quarterly total liabilities is now -83.39% below its all-time high of $550.34 million, reached on September 30, 2021.
Performance
ITOS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ITOS Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.8% | -1.1% |
| 3 y3 years | +332.4% | -83.4% |
| 5 y5 years | +648.6% | - |
ITOS Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -72.2% | +0.8% | -72.5% | +20.1% |
| 5 y | 5-year | -72.2% | +332.4% | -83.4% | +651.5% |
| alltime | all time | -72.2% | +648.6% | -83.4% | +651.5% |
ITeos Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $91.39 M(+3.9%) |
| Jun 2024 | - | $87.97 M(-0.7%) |
| Mar 2024 | - | $88.57 M(-4.1%) |
| Dec 2023 | $92.36 M(+0.8%) | $92.36 M(+16.3%) |
| Sep 2023 | - | $79.38 M(-1.0%) |
| Jun 2023 | - | $80.22 M(+5.4%) |
| Mar 2023 | - | $76.08 M(-17.0%) |
| Dec 2022 | $91.66 M | $91.66 M(-36.2%) |
| Sep 2022 | - | $143.67 M(-19.0%) |
| Jun 2022 | - | $177.47 M(-20.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $223.94 M(-32.5%) |
| Dec 2021 | $331.89 M(+1453.7%) | $331.89 M(-39.7%) |
| Sep 2021 | - | $550.34 M(+1785.6%) |
| Jun 2021 | - | $29.19 M(+43.9%) |
| Mar 2021 | - | $20.28 M(-5.1%) |
| Dec 2020 | $21.36 M(-68.0%) | $21.36 M(+39.5%) |
| Sep 2020 | - | $15.32 M(+26.0%) |
| Jun 2020 | - | $12.16 M(-16.2%) |
| Mar 2020 | - | $14.52 M(-78.3%) |
| Dec 2019 | $66.83 M(+441.7%) | $66.83 M |
| Dec 2018 | $12.34 M | - |
FAQ
- What is iTeos Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for iTeos Therapeutics?
- What is iTeos Therapeutics annual total liabilities year-on-year change?
- What is iTeos Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for iTeos Therapeutics?
- What is iTeos Therapeutics quarterly total liabilities year-on-year change?
What is iTeos Therapeutics annual total liabilities?
The current annual total liabilities of ITOS is $92.36 M
What is the all time high annual total liabilities for iTeos Therapeutics?
iTeos Therapeutics all-time high annual total liabilities is $331.89 M
What is iTeos Therapeutics annual total liabilities year-on-year change?
Over the past year, ITOS annual total liabilities has changed by +$701.00 K (+0.76%)
What is iTeos Therapeutics quarterly total liabilities?
The current quarterly total liabilities of ITOS is $91.39 M
What is the all time high quarterly total liabilities for iTeos Therapeutics?
iTeos Therapeutics all-time high quarterly total liabilities is $550.34 M
What is iTeos Therapeutics quarterly total liabilities year-on-year change?
Over the past year, ITOS quarterly total liabilities has changed by -$975.00 K (-1.06%)